Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

FOLIC ACID

Unique Identifier:SPE01502020
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:
Molecular Weight:423.255 g/mol
X log p:6.291  (online calculus)
Lipinksi Failures2
TPSA105.36
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:13
Rotatable Bond Count:10
Canonical Smiles:NC1Nc2ncc(CNc3ccc(cc3)C(=O)NC(CCC(O)=O)C(O)=O)nc2C(=O)N=1
Class:alkaloid
Source:liver, kidney, green plants and fungi
Therapeutics:hematopoietic vitamin
Generic_name:Folic Acid
Chemical_iupac_name:2-[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioic acid
Drug_type:Experimental
Pharmgkb_id:PA449692
Kegg_compound_id:C00504
Drugbank_id:EXPT01468
Melting_point:250 oC
H2o_solubility:slight
Cas_registry_number:59-30-3
Drug_category:ATC:B03BB01; Dietary supplement; Micronutrient
Indication:For treatment of folic acid deficiency, megaloblastic anemia and in anemias of
nutritional supplements, pregnancy, infancy, or childhood.
Pharmacology:Folic acid, a water-soluble B-complex vitamin, is found in foods such as liver,
kidneys, yeast, and leafy, green vegetables. Folic acid is used to diagnose folate
deficiency and to treat topical sprue and megaloblastic and macrocytic anemias,
hematologic complications resulting from a deficiency in folic acid.
Mechanism_of_action:Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid
and methyltetrahydrofolate by dihydrofolate reductase. These folic acid congeners
are transported across cells by receptor-mediated endocytosis where they are needed
to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids,
interconvert amino acids, methylate tRNA, and generate and use formate. Using
vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by
remethylation of homocysteine to methionine via methionine synthetase.
Organisms_affected:Humans and other mammals

Found: 205 nonactive as graph: single | with analogs 2 3 4 5 6 7 8 9 10  Next >> [205]
Species: 4932
Condition: APC9
Replicates: 2
Raw OD Value: r im 0.6607±0.00968736
Normalized OD Score: sc h 0.9574±0.0114474
Z-Score: -2.3176±0.656838
p-Value: 0.0346284
Z-Factor: -2.36072
Fitness Defect: 3.3631
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Spectrum
Plate Number and Position:6|H2
Drug Concentration:50.00 nM
OD Absorbance:600 nm
Robot Temperature:22.90 Celcius
Date:2007-11-22 YYYY-MM-DD
Plate CH Control (+):0.042225±0.00072
Plate DMSO Control (-):0.688175±0.02109
Plate Z-Factor:0.8974
png
ps
pdf

DBLink | Rows returned: 82 Next >> 
3405 2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
6037 (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
22986 disodium (2R)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioate
22987 (2R)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
86481 potassium
(4S)-4-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]-5-hydroxy-5-oxo-pentanoate
1549092 (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioate

internal high similarity DBLink | Rows returned: 0

active | Cluster 5590 | Additional Members: 8 | Rows returned: 1
SPE01500679 0

Service provided by the Mike Tyers Laboratory